RE: Does the company needs to wait 2025?16 Oct 2024 09:32
Market analyst - No market access and funding is immediate. No waiting.
“ Feedback plc ("Feedback" or the "Company"), the clinical infrastructure specialist, announces that the Diagnostic Enhanced Advice and Guidance diversions achieved through the Bleepa platform are now eligible for reimbursement under the Elective Recovery Fund ("ERF") and that any Integrated Care Board ("ICB") or hospital in England will, with IMMEDIATE effect be able to utilise this funding, by local agreement, to reimburse expenditure on the Bleepa technology.”